NCT01176916 Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China Status COMPLETED Phase PHASE4
NCT01176058 A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis Status TERMINATED Phase PHASE3
NCT01175135 An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia Status COMPLETED Phase PHASE2
NCT01173757 To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01172821 Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II Status COMPLETED Phase PHASE3
NCT01172808 Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma I Status COMPLETED Phase PHASE3
NCT01172652 Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD) Status COMPLETED Phase PHASE4
NCT01169714 A Study To Observe Safety And Blood Concentrations Of PF-04995274 During And Following the Administration of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Volunteers. Status COMPLETED Phase PHASE1
NCT01168934 A Phase 1 Absolute Bioavailability Study For Oral Crizotinib In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01166724 Renal Allograft Function and Histology Following Switching From A Tacrolimus to Sirolimus (SRL)-Based Immunosuppression- Status TERMINATED Phase PHASE3
NCT01166555 Pharmacokinetics And Tolerability Of Subcutaneous Administration Of PF 04236921 In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01165736 To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity Status COMPLETED Phase PHASE1
NCT01165723 A Clinical Study Evaluating The Safety And Tolerability Of PF-04427429 In Healthy Adult Volunteers. The Pharmacokinetics And Pharmacodynamics Of PF-04427429 Will Also Be Investigated Status COMPLETED Phase PHASE1
NCT01164579 Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE2
NCT01163851 Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin Status COMPLETED Phase PHASE1
NCT01163838 Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia Status WITHDRAWN Phase PHASE1
NCT01163253 A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis Status TERMINATED Phase PHASE3
NCT01162889 Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People Status TERMINATED Phase PHASE1